Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Controlled Trial of the Effectiveness of Intermittent Surface Neuromuscular Stimulation Using the Geko™ Device Compared With Intermittent Pneumatic Compression to Prevent Venous Thromboembolism in Immobile Acute Stroke Patients

NCT05476913 is registered in ClinicalTrials.gov with Firstkind Ltd as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05476913 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Controlled Trial of the Effectiveness of Intermittent Surface Neuromuscular Stimulation Using the Geko™ Device Compared With Intermittent Pneumatic Compression to Prevent Venous Thromboembolism in Immobile Acute Stroke Patients
Lead sponsor
Firstkind Ltd
Phase
Not applicable
Overall status
Recruiting
Start date
July 6, 2023
Completion date
June 30, 2025
Enrollment
1,200 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

deep vein thrombosis, pulmonary embolism, stroke, acute, venous thromboembolism